id: NEW:digital_mental_health_intervention_to_depression_diagnosis
name: Digital Interventions for Depression and Alcohol Use â†’ Depressive Symptoms
from_node:
  node_id: NEW:digital_mental_health_intervention
  node_name: Digital Interventions for Depression and Alcohol Use
to_node:
  node_id: depression_diagnosis
  node_name: Depressive Symptoms
direction: negative
category: behavioral
mechanism_pathway:
- 'Step 1: Digital interventions deliver evidence-based therapeutic content (e.g.,
  cognitive behavioral therapy, motivational interviewing) targeting both depressive
  symptoms and problematic alcohol use simultaneously'
- 'Step 2: Users engage with structured modules addressing negative thought patterns,
  behavioral activation, and alcohol use reduction strategies through accessible digital
  platforms'
- 'Step 3: Integrated treatment approach addresses the bidirectional relationship
  between depression and alcohol use, reducing both conditions concurrently'
- 'Step 4: Sustained engagement with digital interventions leads to measurable reductions
  in depressive symptoms, with small but significant effects observed at 3-month follow-up'
evidence:
  quality_rating: A
  n_studies: 6
  primary_citation: 'M. Schouten et al. 2021. Digital Interventions for People With
    Co-Occurring Depression and Problematic Alcohol Use: A Systematic Review and Meta-Analysis.
    Alcohol and Alcoholism.'
  supporting_citations: []
description: Digital interventions targeting both depression and problematic alcohol
  use simultaneously produce small but significant reductions in depressive symptoms
  at 3-month follow-up among people with co-occurring conditions. The pooled effect
  size (Hedges' g = 0.34) indicates a small beneficial effect favoring digital interventions
  over comparators.
last_updated: '2025-12-02'
extraction_method: consolidated_batch_v3
quantitative_effects:
  effect_size:
    value: 0.34
    type: hedges_g
    ci_lower: 0.06
    ci_upper: 0.62
  p_value: 0.02
  sample_size: null
moderators:
- name: Follow-up duration
  direction: weakens
  strength: moderate
  description: Effects on depressive symptoms were significant at 3-month follow-up
    (g=0.34, p=0.02) but non-significant at 6-month follow-up (g=0.29, p=0.15), suggesting
    potential attenuation of effects over time
